Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test (Q69871945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Altered PABA pharmacokinetics in cystic fibrosis. Implications for bentiromide test (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

1 reference

1

G Koren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

Z Weizman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

G Forstner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

S M MacLeod

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

P R Durie

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 October 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

928-932

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3875462%20AND%20SRC:MED&resulttype=core&format=json

Oral administration of a chymotrypsin-labile peptide--a new test of exocrine pancreatic function in man (PFT)

6 October 2019

cites work

1 reference

12 December 2020

Dosing implications of altered gentamicin disposition in patients with cystic fibrosis

1 reference

12 December 2020

Diagnosis of exocrine pancreatic insufficiency in cystic fibrosis by the synthetic peptide N-benzoyl-l-tyrosyl-p-aminobenzoic acid

1 reference

12 December 2020

BT-PABA test with plasma PABA measurements: evaluation of sensitivity and specificity

1 reference

12 December 2020

Determination of protease-cleaved p-aminobenzoic acid (PABA) in serum after oral administration of N-benzoyl-L-tyrosyl-p-aminobenzoic acid (PABA-peptide) in children

1 reference

12 December 2020

Diagnosis of pancreatic disease by a synthetic peptide. A new test of exocrine pancreatic function

1 reference

12 December 2020

Bentiromide test for assessing pancreatic dysfunction using analysis of para-aminobenzoic acid in plasma and urine. Studies in cystic fibrosis and Shwachman's syndrome

1 reference

12 December 2020

Rapid method for the determination of fat in feces

1 reference

12 December 2020

Bentiromide as a test of exocrine pancreatic function in adult patients with pancreatic exocrine insufficiency. Determination of appropriate dose and urinary collection interval

1 reference

12 December 2020

THE RENAL CLEARANCES OF SUBSTITUTED HIPPURIC ACID DERIVATIVES AND OTHER AROMATIC ACIDS IN DOG AND MAN.

1 reference

12 December 2020

Theophylline disposition in cystic fibrosis

1 reference

12 December 2020

Difference in renal handling of cefsulodin between patients with cystic fibrosis and normal subjects

1 reference

12 December 2020